BIOMAT Database Logo BIOMAT Database Logo

Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. 1997

A E Deconinck, and J A Rafael, and J A Skinner, and S C Brown, and A C Potter, and L Metzinger, and D J Watt, and J G Dickson, and J M Tinsley, and K E Davies
Department of Biochemistry, University of Oxford, United Kingdom.

The absence of dystrophin at the muscle membrane leads to Duchenne muscular dystrophy (DMD), a severe muscle-wasting disease that is inevitably fatal in early adulthood. In contrast, dystrophin-deficient mdx mice appear physically normal despite their underlying muscle pathology. We describe mice deficient for both dystrophin and the dystrophin-related protein utrophin. These mice show many signs typical of DMD in humans: they show severe progressive muscular dystrophy that results in premature death, they have ultrastructural neuromuscular and myotendinous junction abnormalities, and they aberrantly coexpress myosin heavy chain isoforms within a fiber. The data suggest that utrophin and dystrophin have complementing roles in normal functional or developmental pathways in muscle. Detailed study of these mice should provide novel insights into the pathogenesis of DMD and provide an improved model for rapid evaluation of gene therapy strategies.

UI MeSH Term Description Entries
D008297 Male Males
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D009137 Muscular Dystrophy, Animal MUSCULAR DYSTROPHY that occurs in VERTEBRATE animals. Animal Muscular Dystrophies,Animal Muscular Dystrophy,Dystrophies, Animal Muscular,Dystrophy, Animal Muscular,Muscular Dystrophies, Animal
D009469 Neuromuscular Junction The synapse between a neuron and a muscle. Myoneural Junction,Nerve-Muscle Preparation,Junction, Myoneural,Junction, Neuromuscular,Junctions, Myoneural,Junctions, Neuromuscular,Myoneural Junctions,Nerve Muscle Preparation,Nerve-Muscle Preparations,Neuromuscular Junctions,Preparation, Nerve-Muscle,Preparations, Nerve-Muscle
D011950 Receptors, Cholinergic Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology. ACh Receptor,Acetylcholine Receptor,Acetylcholine Receptors,Cholinergic Receptor,Cholinergic Receptors,Cholinoceptive Sites,Cholinoceptor,Cholinoceptors,Receptors, Acetylcholine,ACh Receptors,Receptors, ACh,Receptor, ACh,Receptor, Acetylcholine,Receptor, Cholinergic,Sites, Cholinoceptive
D003598 Cytoskeletal Proteins Major constituent of the cytoskeleton found in the cytoplasm of eukaryotic cells. They form a flexible framework for the cell, provide attachment points for organelles and formed bodies, and make communication between parts of the cell possible. Proteins, Cytoskeletal
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013710 Tendons Fibrous bands or cords of CONNECTIVE TISSUE at the ends of SKELETAL MUSCLE FIBERS that serve to attach the MUSCLES to bones and other structures. Endotenon,Epotenon,Tendons, Para-Articular,Tendons, Paraarticular,Endotenons,Epotenons,Para-Articular Tendon,Para-Articular Tendons,Paraarticular Tendon,Paraarticular Tendons,Tendon,Tendon, Para-Articular,Tendon, Paraarticular,Tendons, Para Articular

Related Publications

A E Deconinck, and J A Rafael, and J A Skinner, and S C Brown, and A C Potter, and L Metzinger, and D J Watt, and J G Dickson, and J M Tinsley, and K E Davies
Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin-deficient mice and Duchenne muscular dystrophy.
June 2018, FEBS letters,
A E Deconinck, and J A Rafael, and J A Skinner, and S C Brown, and A C Potter, and L Metzinger, and D J Watt, and J G Dickson, and J M Tinsley, and K E Davies
Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy.
August 1997, Cell,
A E Deconinck, and J A Rafael, and J A Skinner, and S C Brown, and A C Potter, and L Metzinger, and D J Watt, and J G Dickson, and J M Tinsley, and K E Davies
Metabolic dysfunction and altered mitochondrial dynamics in the utrophin-dystrophin deficient mouse model of duchenne muscular dystrophy.
January 2015, PloS one,
A E Deconinck, and J A Rafael, and J A Skinner, and S C Brown, and A C Potter, and L Metzinger, and D J Watt, and J G Dickson, and J M Tinsley, and K E Davies
Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy.
January 2014, PloS one,
A E Deconinck, and J A Rafael, and J A Skinner, and S C Brown, and A C Potter, and L Metzinger, and D J Watt, and J G Dickson, and J M Tinsley, and K E Davies
The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy.
July 2019, Human molecular genetics,
A E Deconinck, and J A Rafael, and J A Skinner, and S C Brown, and A C Potter, and L Metzinger, and D J Watt, and J G Dickson, and J M Tinsley, and K E Davies
Dystrophin, utrophin, and muscular dystrophy.
March 1995, The New England journal of medicine,
A E Deconinck, and J A Rafael, and J A Skinner, and S C Brown, and A C Potter, and L Metzinger, and D J Watt, and J G Dickson, and J M Tinsley, and K E Davies
Utrophin therapy for Duchenne muscular dystrophy?
November 2004, The Lancet. Neurology,
A E Deconinck, and J A Rafael, and J A Skinner, and S C Brown, and A C Potter, and L Metzinger, and D J Watt, and J G Dickson, and J M Tinsley, and K E Davies
Micro-utrophin Therapy for Duchenne Muscular Dystrophy.
November 2019, Molecular therapy : the journal of the American Society of Gene Therapy,
A E Deconinck, and J A Rafael, and J A Skinner, and S C Brown, and A C Potter, and L Metzinger, and D J Watt, and J G Dickson, and J M Tinsley, and K E Davies
Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review.
January 2024, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,
A E Deconinck, and J A Rafael, and J A Skinner, and S C Brown, and A C Potter, and L Metzinger, and D J Watt, and J G Dickson, and J M Tinsley, and K E Davies
Correction to: The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy.
October 2023, Human molecular genetics,
Copied contents to your clipboard!